VALN Valneva SE

NASDAQ
$7.13

Valneva SE (VALN) is expected to report earnings on November 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +30.8% since its last earnings release on August 13, 2026.

Valneva SE Missed Consensus Estimates
Thursday, August 13, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · Before Open
Earnings Whisper
-
vs ($0.17)
Rev est $42.97M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.12

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Valneva SE

Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France.

Sector

Healthcare

Industry

Drug Manufacturers/Other